Sunovion Pharmaceuticals, Inc.

Sunovion Pharmaceuticals, Inc.

Sunovion Pharmaceuticals, Inc.

Overview
Date Founded

1984

Headquarters

84 Waterford Drive, Marlborough, Massachusetts, 01752, United States

Type of Company

Private

Employees (Worldwide)

2,400

Industries

Pharmaceuticals
Biotechnology

Company Description

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s vision is to lead the way to a healthier world. The company’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc.

Contact Data
Trying to get in touch with decision makers at Sunovion Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, General Counsel & Corporate Secretary

Senior Vice President & Chief Commercial Officer

Head of Global Business Development

Executive Vice President & Chief Administrative Officer

Executive Vice President, Chief Corporate Strategy Officer

Senior Vice President, Chief Human Resources Officer

Senior Vice President, Chief Quality & Technical Operations Officer

Executive Director

Paths to Sunovion Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Sunovion Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Sunovion Pharmaceuticals, Inc., Sumitomo Chemical Co Ltd., Sunovion CNS Development Canada ULC purchase Cynapsus Therapeutics, Inc.

Details Hidden

Sumitomo Dainippon Pharma, Sunovion Pharmaceuticals, Inc. purchase Elevation Pharmaceuticals, Inc. from Mesa Verde Ventures LLC, Canaan Management, Inc., Care Capital LLC, TPG Growth LLC resulting in a new company Sunovion Respiratory Development, Inc.

Details Hidden

Sumitomo Dainippon Pharma purchases Sunovion Pharmaceuticals, Inc.

Transaction Advisors
Accountant

Advised onSunovion Pharmaceuticals, Inc. purchases Sterling Organics Ltd from Montagu Private Equity LLP

Investment Advisor

Advised onSumitomo Dainippon Pharma purchases Sunovion Pharmaceuticals, Inc.

Legal Advisor

Advised onSumitomo Dainippon Pharma, Sunovion Pharmaceuticals, Inc. purchase Elevation Pharmaceuticals, Inc. from Mesa Verde Ventures LLC, Canaan Management, Inc., Care Capital LLC, TPG Growth LLC resulting in a new company Sunovion Respiratory Development, Inc.

Consultant

Advised onSumitomo Dainippon Pharma, Sunovion Pharmaceuticals, Inc. purchase Elevation Pharmaceuticals, Inc. from Mesa Verde Ventures LLC, Canaan Management, Inc., Care Capital LLC, TPG Growth LLC resulting in a new company Sunovion Respiratory Development, Inc.

Legal Advisor

Advised onSumitomo Dainippon Pharma purchases Sunovion Pharmaceuticals, Inc.

Counsel

Advised onSumitomo Dainippon Pharma purchases Sunovion Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Chair, Corporate Practice Group at Wilmer Cutler Pickering Hale and Dorr LLP

Legal Advisor

Chair, Transactional Department at Wilmer Cutler Pickering Hale and Dorr LLP

Legal Advisor

Co-Managing Partner at Wilmer Cutler Pickering Hale and Dorr LLP

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$692M
Non-Profit Donations & Grants
Political Donations
$500
2013
$500
2013
$500
2013
Investments
Details Hidden

Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.

Investors
Details Hidden

Founder at Sunovion Pharmaceuticals, Inc.

Details Hidden

President at Xiphos Pharmaceuticals, Inc.

Details Hidden

Chairman & Chief Executive Officer at Bionevia Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sunovion Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sunovion Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sunovion Pharmaceuticals, Inc..